Background: The role of tranexamic acid (TXA) in reducing blood loss following primary
shoulder arthroplasty has been demonstrated in small retrospective and controlled clinical …

Tranexamic acid (TXA) is an antifibrinolytic agent that has been shown to decrease blood
loss and transfusion rates after knee and hip arthroplasty, however with only limited …

Background Complications and revisions following anatomic (aTSA) and reverse (rTSA)
total shoulder arthroplasty have deleterious effects on patient function and satisfaction. The …

Background: There have been few studies that have evaluated ambulatory total shoulder
arthroplasty. The objectives of the present study were to investigate the current trends in …

Background Recent emphasis on safe and efficient delivery of high-quality health care has
increased interest in outpatient total joint arthroplasty. The purpose of this study was to …

Background Proximal humerus fracture treatment varies by surgeon preference and patient
factors. This study compares patient and fracture characteristics, with outcomes between …

Background The rate of total shoulder arthroplasty (TSA) is rising, which has an impact on
health care expenditure. One avenue to mitigate cost is outpatient TSA. There are currently …

Background Patients undergoing reverse total shoulder arthroplasty (RTSA) are at risk of
significant perioperative blood loss. To date, few studies have examined the effectiveness of …

Background There is currently a paucity of non-database studies looking at safety and
outcomes after outpatient shoulder arthroplasty. The purpose of this study was to report our …

Objectives To provide accurate risk estimates of serious adverse events after elective
shoulder replacement surgery for arthritis, including age and sex specific estimates of the …